Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: An open label study;Impact cognitif d'un traitement associant mitoxantrone et méthylprednisolone dans la sclérose en plaques

Revue Neurologique

Volumn 164, Issue 1, 2008, Pages 47-52

  Zephir H ^a   de Seze J ^a   Dujardin, K ^b   Dubois, G ^b   Cabaret, M ^a   Bouillaguet, S ^a   Ferriby, D ^a   Stojkovic, T ^a   Vermersch, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Cognition; Methylprednisolone; Mitoxantrone; Multiple sclerosis

Indexed keywords

GADOLINIUM; METHYLPREDNISOLONE; MITOXANTRONE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; HUMAN; LEARNING; MEMORY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME; CLINICAL TRIAL; DEPRESSION; DISEASE COURSE; FEMALE; MALE; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE;

ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS; COGNITION DISORDERS; DEPRESSION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MEMORY; METHYLPREDNISOLONE; MITOXANTRONE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 42449102161     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2007.08.003     Document Type: Article

References (24)

1. A. Achiron Y. Barak Effect of interferon beta 1b on cognitive functions in multiple sclerosis European Neurology 47 2002 11 14
2. M.P. Amato G. Ponziani G. Siracusa S. Sorbi Cognitive dysfunction in early-onset multiple sclerosis. A reappraisal after 10 years Archives of Neurology 58 2001 1602 1606
3. W.W. Beatty Assessment of cognitive and psychological functions in patients with multiple sclerosis: considerations for databasing Multiple Sclerosis 5 1999 239 243
4. Beck, A.T., Stear, R.A., Brown, G.K. (1998). Manuel de l’inventaire de dépression de Beck (2nd ed.). Éditions du centre de psychologie appliquée. Paris.
5. Corsi, P. (1972). Human memory and the medial temporal region of the brain. Unpublished PhD Thesis, McGill University.
6. K. Dujardin P. Krystkowiak L. Defebvre S. Blond A case of severe dysexecutive syndrome consecutive to chronic bilateral pallidal stimulation Neuropsychologia 38 2000 1305 1315
7. G. Edan D. Miller M. Clanet Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria Journal of Neurology, Neurosurgery, and Psychiatry 62 1997 112 118
8. J.S. Fischer R.L. Priore L.D. Jacobs Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis Annals of Neurology 48 2000 885 892
9. R.G. Ghalie G. Edan M. Laurent Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS Neurology 59 2000 909 913
10. R.G. Ghalie E. Mauch G. Edan A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis Multiple Sclerosis 8 2002 441 445
11. O. Godefroy M. Rousseaux D. Leys Frontal lobe dysfunction in unilateral lenticulostriate infarcts. Prominent role of cortical lesions Archives of Neurology 49 1992 1285 1289
12. E. Grober H. Buschke Genuine memory deficits in dementia Developmental Neuropsychology 3 1987 13 36
13. H.P. Hartung R. Gonsette N. Konig Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial Lancet 360 2002 2018 2025
14. M.J. Hohol M.J. Olek E.J. Orav Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease Multiple Sclerosis 5 1999 403 409
15. J. Kesselring U. Klement Cognitive and affective disturbances in multiple sclerosis Journal of Neurology 248 2001 180 183
16. P.A. Keenan M.W. Jacobson R.M. Soleymani The effect on memory of chronic prednisone treatment in patients with systemic disease Neurology 47 1996 1396 1402
17. P. Kujala R. Portin J. Rutiainen The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up Brain 120 1997 289 297
18. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
19. W.I. McDonald A. Compston G. Edan Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Annals of Neurology 50 2001 121 127
20. S. Nollet E. Berger E. Deconinck Leukemia in two multiple sclerosispatients treated with mitoxantrone Revue Neurologique 162 2006 195 199
21. R.L. Oliveri G. Sibilia P. Valentino Pulsed methylprednisolone induces a reversible impairment of memory in patients in relapsing-remitting meultiple sclerosis Acta Neurologica Scandinavica 97 1998 366 369
22. T. Patzold M. Schwengelbeck L.M. Ossege Changes of the MS Functional Composite EDSS during and after treatment of relapses with methylprednisolone in patients with MS Acta Neurologica Scandinavica 105 2002 164 168
23. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised manual. The Psychological Corporation. New York.
24. H. Zéphir J. de Sèze K. Dujardin One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis Multiple Sclerosis 11 2005 360 363